Evidence map›Paper›PMID 32490278›Full record

ArticleIBRO reports2020

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects.

Chengai Xu, Carl M Sellgren, Helena Fatouros-Bergman, Fredrik Piehl, Kaj Blennow, Henrik Zetterberg, Ann Brinkmalm, Alexander Frizell Santillo, Sofia Lundgren, Simon Cervenka and 3 more

Abstract read
In one paragraph

Article in IBRO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chengai XuDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Carl M SellgrenDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Helena Fatouros-BergmanCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm & Stockholm Health Care Services, Stockholm County Council, Sweden.
Fredrik PiehlNeuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Ann BrinkmalmDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Alexander Frizell SantilloCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
Sofia LundgrenClinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Simon CervenkaCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm & Stockholm Health Care Services, Stockholm County Council, Sweden.
Göran EngbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Sophie ErhardtDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Karolinska Schizophrenia Project (KaSP) Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-mortem studies consistently show evidence of reduced synaptic protein levels in patients with schizophrenia. Clinically high-risk subjects show a steeper decrease in grey matter thickness and

Indexed as

BACS-SC, Brief Assessment of Cognition in Schizophrenia Symbol CodingBMI, body mass indexBVMT-R, Brief Visuospatial Memory Test-RevisedCGI, Clinical Global ImpressionCPT-IP, Continuous Performance Test-Identical PairsDUP, duration of untreated psychosisFEP, first-episode psychosisGAF, Global Assessment of FunctioningHC, healthy controlsHVLT-R, Hopkins Verbal Learning Test-RevisedLNS, Letter-Number SpanMSCEIT, Mayer–Salovey– Caruso Emotional Intelligence TestNAB: MAZES, Neuropsychological Assessment Battery: MazesPANSS, the Positive and Negative Syndrome ScaleSchizophreniaSNAP-25Synapse pruningSYT-1TMT, Trail Making TestWMS-III, Wechsler Memory Scale-3rd Edition

Identifiers

PMID32490278
PMCPMC7262376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.